Literature DB >> 25165039

Modeling of bounded outcome scores with data on the boundaries: application to disability assessment for dementia scores in Alzheimer's disease.

Xu Steven Xu1, Mahesh Samtani, Min Yuan, Partha Nandy.   

Abstract

Mixed-effects beta regression (BR), boundary-inflated beta regression (ZOI), and coarsening model (CO) were investigated for analyzing bounded outcome scores with data at the boundaries in the context of Alzheimer's disease. Monte Carlo simulations were conducted to simulate disability assessment for dementia (DAD) scores using these three models, and each set of simulated data were analyzed by the original simulation model. One thousand trials were simulated, and each trial contained 250 subjects. For each subject, DAD scores were simulated at baseline, 13, 26, 39, 52, 65, and 78 weeks. The simulation-reestimation exercise showed that all the three models could reasonably recover their true parameter values. The bias of the parameter estimates of the ZOI model was generally less than 1%, while the bias of the CO model was mainly within 5%. The bias of the BR model was slightly higher, i.e., less than or in the order of 20%. In the application to real-world DAD data from clinical studies, examination of prediction error and visual predictive check (VPC) plots suggested that both BR and ZOI models had similar predictive performance and described the longitudinal progression of DAD slightly better than the CO model. In conclusion, the investigated three modeling approaches may be sensible choices for bounded outcome scores with data on the edges. Prediction error and VPC plots can be used to identify the model with best predictive performance.

Entities:  

Mesh:

Year:  2014        PMID: 25165039      PMCID: PMC4389746          DOI: 10.1208/s12248-014-9655-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  19 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Modeling of Functional Assessment Questionnaire (FAQ) as continuous bounded data from the ADNI database.

Authors:  K Ito; M M Hutmacher; B W Corrigan
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-09-19       Impact factor: 2.745

3.  Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

Authors:  I Gélinas; L Gauthier; M McIntyre; S Gauthier
Journal:  Am J Occup Ther       Date:  1999 Sep-Oct

4.  The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease.

Authors:  H Feldman; A Sauter; A Donald; I Gélinas; S Gauthier; K Torfs; W Parys; A Mehnert
Journal:  Alzheimer Dis Assoc Disord       Date:  2001 Apr-Jun       Impact factor: 2.703

5.  Bounded outcome score modeling: application to treating psoriasis with ustekinumab.

Authors:  Chuanpu Hu; Newman Yeilding; Hugh M Davis; Honghui Zhou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-06-18       Impact factor: 2.745

6.  Estimating overall exposure effects for zero-inflated regression models with application to dental caries.

Authors:  Jeffrey M Albert; Wei Wang; Suchitra Nelson
Journal:  Stat Methods Med Res       Date:  2011-09-08       Impact factor: 3.021

7.  Disease progression meta-analysis model in Alzheimer's disease.

Authors:  Kaori Ito; Sima Ahadieh; Brian Corrigan; Jonathan French; Terence Fullerton; Thomas Tensfeldt
Journal:  Alzheimers Dement       Date:  2009-07-09       Impact factor: 21.566

8.  Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.

Authors:  N H Holford; K E Peace
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

9.  Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.

Authors:  N H Holford; K E Peace
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries.

Authors:  Xu Steven Xu; Mahesh N Samtani; Adrian Dunne; Partha Nandy; An Vermeulen; Filip De Ridder
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-05-05       Impact factor: 2.745

View more
  3 in total

1.  Improvement in latent variable indirect response modeling of multiple categorical clinical endpoints: application to modeling of guselkumab treatment effects in psoriatic patients.

Authors:  Chuanpu Hu; Bruce Randazzo; Amarnath Sharma; Honghui Zhou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-06-20       Impact factor: 2.745

2.  Differences in ambulatory care fragmentation between cancer survivors and noncancer controls.

Authors:  Laura C Pinheiro; Evgeniya Reshetnyak; Monika M Safford; David Nanus; Lisa M Kern
Journal:  Cancer       Date:  2020-04-14       Impact factor: 6.860

3.  Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials.

Authors:  Steven X Xu; Mahesh N Samtani; Alberto Russu; Omoniyi J Adedokun; Ming Lu; Kaori Ito; Brian Corrigan; Sangeeta Raje; H Robert Brashear; Scot Styren; Chuanpu Hu
Journal:  Alzheimers Dement (N Y)       Date:  2015-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.